{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:15:11Z","timestamp":1772050511243,"version":"3.50.1"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Human \u03b3\u03b4T cells are a special immune cell type which exist in small quantities in the body, do not require processing and presentation for antigen recognition, and have non-major histocompatibility complex (MHC)-restricted immune response. They play an important role in the body\u2019s anti-tumor, anti-infection, immune regulation, immune surveillance and maintenance of immune tolerance. This article reviews the generation and development of human \u03b3\u03b4T cells, genetic characteristics, classification, recognition and role of antigens, and research progress in tumor immunotherapy.<\/jats:p>","DOI":"10.3389\/fgene.2022.1077419","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:26:51Z","timestamp":1672846011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Biological characteristics of \u03b3\u03b4T cells and application in tumor immunotherapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Renhong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/ijc.28217","article-title":"Human V\u03b32V\u03b42 T cells limit breast cancer growth by modulating cell survival-apoptosis-related molecules and microenvironment in tumors","volume":"133","author":"Aggarwal","year":"2013","journal-title":"Int. J. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","article-title":"Delta one T cells for immunotherapy of chronic lymphocytic leukemia: Clinical-grade expansion\/differentiation and preclinical proof of concept","volume":"22","author":"Almeida","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.omto.2020.04.013","article-title":"Electroporation of Nkg2d rna car improves V\u03b39v\u03b42\u00a0T cell responses against human solid tumor xenografts","volume":"17","author":"Ang","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.canlet.2014.11.030","article-title":"Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced V\u03b39V\u03b42 T cell cytotoxicity in PC-3 prostate cancer cells","volume":"357","author":"Arkko","year":"2015","journal-title":"Cancer Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-15-0054","article-title":"IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment","volume":"75","author":"Benevides","year":"2015","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00262-008-0491-8","article-title":"Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma","volume":"57","author":"Bennouna","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","article-title":"Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","volume":"57","author":"Bouet-Toussaint","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","article-title":"Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses","volume":"106","author":"Brandes","year":"2009","journal-title":"Pro Natl. Acad. Sci. U. S. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gammadelta T Cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7314\/apjcp.2014.15.2.775","article-title":"Low counts of \u03b3\u03b4 T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection","volume":"15","author":"Cai","year":"2014","journal-title":"Asian Pac J. Cancer Prev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000100878","article-title":"Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma","volume":"214","author":"Campillo","year":"2007","journal-title":"Dermatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4049\/jimmunol.1100681","article-title":"Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer[J]","volume":"187","author":"Capietto","year":"2011","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.4049\/jimmunol.0901334","article-title":"Cutting edge: TGF-beta1 and IL-15 induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation","volume":"183","author":"Casetti","year":"2009","journal-title":"J. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/CJI.0b013e3181dda207","article-title":"Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells","volume":"33","author":"Chargui","year":"2010","journal-title":"J. Immunother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.dci.2011.08.018","article-title":"Somatic hypermutation of TCR \u03b3 V genes in the sandbar shark","volume":"37","author":"Chen","year":"2012","journal-title":"Dev. Comp. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/icb.2017.21","article-title":"Synergistic targeting of breast cancer stem-like cells by human \u03b3\u03b4 T cells and CD8+ T cells","volume":"95","author":"Chen","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12967-019-1897-0","article-title":"Distribution and functions of \u03b3\u03b4 T cells infiltrated in the ovarian cancer microenvironment","volume":"17","author":"Chen","year":"2019","journal-title":"J. Transl. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e5838582","DOI":"10.1155\/2021\/5838582","article-title":"Study on the killing effect of \u03b3\u03b4T cells activated by rukangyin on breast cancer MDA-MB-231 cells","volume":"2021","author":"Chen","year":"2021","journal-title":"Dis. Markers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni.2240","article-title":"Body-barrier surveillance by epidermal \u03b3\u03b4 TCRs","volume":"13","author":"Chodaczek","year":"2012","journal-title":"Nat. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","article-title":"Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: Role of CD86 and inflammatory cytokines","volume":"174","author":"Conti","year":"2005","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4049\/jimmunol.181.1.309","article-title":"Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness","volume":"181","author":"Cook","year":"2008","journal-title":"J. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jcyt.2015.03.605","article-title":"Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma","volume":"17","author":"Cui","year":"2015","journal-title":"Cytotherapy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","article-title":"\u0393\u03b4 T cells support pancreatic oncogenesis by restraining \u03b1\u03b2 T cell activation","volume":"166","author":"Daley","year":"2016","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.0903454","article-title":"V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells","volume":"184","author":"D\u2019Asaro","year":"2010","journal-title":"J. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41467-018-04076-0","article-title":"The human V\u03b42+ T-cell compartment comprises distinct innate-like V\u03b39+ and adaptive V\u03b39- subsets","volume":"9","author":"Davey","year":"2018","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-13-3451","article-title":"Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies","volume":"20","author":"Deniger","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/jnci\/88.7.436","article-title":"Killing of lamininreceptor-positive human lung cancers by tumor infiltrating lymphocytes bearing \u03b3\u03b4+T-cell receptors[J]","volume":"88","author":"Ferrarini","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"B31","doi-asserted-by":"publisher","first-page":"eabb0192","DOI":"10.1126\/scitranslmed.abb0192","article-title":"Characterization of ascites- and tumor-infiltrating \u03b3\u03b4 T cells reveals distinct repertoires and a beneficial role in ovarian cancer","volume":"13","author":"Foord","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.20030584","article-title":"Gamma delta T cells provide an early source of interferon gamma in tumor immunity","volume":"198","author":"Gao","year":"2003","journal-title":"J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.4049\/jimmunol.1103710","article-title":"Human V\u03b39V\u03b42 T cells specifically recognize and kill acute myeloid leukemic blasts","volume":"188","author":"Gertner-Dardenne","year":"2012","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"E7311","DOI":"10.1073\/pnas.1707547114","article-title":"Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on V\u03b39V\u03b42 T cell activation","volume":"114","author":"Gu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","article-title":"Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset","volume":"120","author":"Harly","year":"2012","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12885-017-3539-3","article-title":"RNA-Transfection of \u03b3\/\u03b4 T cells with a chimeric antigen receptor or an \u03b1\/\u03b2 T-cell receptor: A safer alternative to genetically engineered \u03b1\/\u03b2 T cells for the immunotherapy of melanoma","volume":"17","author":"Harrer","year":"2017","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri1030","article-title":"Immunoregulation in the tissues by gammadelta T cells","volume":"3","author":"Hayday","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1002\/ctm2.800","article-title":"Hepatocellular carcinoma\u2010infiltrating \u03b3\u03b4 T cells are functionally defected and allogenic V\u03b42 + \u03b3\u03b4 T cell can be a promising complement","volume":"12","author":"He","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fimmu.2018.00800","article-title":"Improving the efficiency of V\u03b39V\u03b42 T-cell immunotherapy in cancer","volume":"9","author":"Hoeres","year":"2018","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/liv.12011","article-title":"The activity of \u03b3\u03b4 T cells against paediatric liver tumour cells and spheroids in cell culture","volume":"33","author":"Hoh","year":"2013","journal-title":"Liver Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jgh.12715","article-title":"Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway","volume":"30","author":"Honda","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.13423\/j.cnki.cjcmi.005670","article-title":"Gammadelta T cells stimulated by zoledronate kill osteosarcoma cells","volume":"26","author":"Jiang","year":"2010","journal-title":"Chin. J. Cell Mol. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.intimp.2013.01.022","article-title":"Regulatory functions of \u03b3\u03b4 T cells","volume":"16","author":"Kabelitz","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2014.00344","article-title":"Expanded human blood-derived \u03b3\u03b4T cells display potent antigen-presentation functions","volume":"5","author":"Khan","year":"2014","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1128\/JVI.01211-10","article-title":"Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: A potential animal model for human H1N1 influenza virus","volume":"84","author":"Khatri","year":"2010","journal-title":"J. Virol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/2326-6066.CIR-17-0655","article-title":"IL22 promotes kras-mutant lung cancer by induction of a protumor immune response and protection of stemness properties","volume":"6","author":"Khosravi","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","article-title":"Phase I\/II study of adoptive transfer of \u03b3\u03b4 T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma","volume":"60","author":"Kobayashi","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00262-006-0199-6","article-title":"Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: A pilot study","volume":"56","author":"Kobayashi","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2567.2009.03162.x","article-title":"Human peripheral gammadelta T cells possess regulatory potential","volume":"128","author":"K\u00fchl","year":"2009","journal-title":"Immunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10120-011-0138-x","article-title":"Decreased number and reduced NKG2D expression of V\u03b41 \u03b3\u03b4 T cells are involved in the impaired function of V\u03b41 \u03b3\u03b4 T cells in the tissue of gastric cancer","volume":"15","author":"Kuroda","year":"2012","journal-title":"Gastric Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: A mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B53","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00262-011-1166-4","article-title":"Human ovarian cancer stem-like cells can be efficiently killed by \u03b3\u03b4 T lymphocytes","volume":"61","author":"Lai","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00262-011-1049-8","article-title":"Pilot trial of interleukin-2 and zoledronic acid to augment \u03b3\u03b4 T cells as treatment for patients with refractory renal cell carcinoma","volume":"60","author":"Lang","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B55","first-page":"597","article-title":"Cytotoxic function of gamma delta (gamma\/delta) T cells against pamidronate-treated cervical cancer cells","volume":"51","author":"Lertworapreecha","year":"2013","journal-title":"Indian J. Exp. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"E280","DOI":"10.25011\/cim.v33i5.14353","article-title":"Effect of ex vivo-expanded \u03b3\u03b4-T cells combined with galectin-1 antibody on the growth of human cervical cancer xenografts in SCID mice","volume":"33","author":"Li","year":"2010","journal-title":"Clin. Invest. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.11969\/j.issn.1673-548X.2020.02.014","article-title":"Role of serum containing rukangyin on invasion of breast cancer MDA-MB-231 cells[J]","volume":"49","author":"Li","year":"2020","journal-title":"J. Med. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/cancers14112749","article-title":"Targeting immunosuppressive tumor-associated macrophages using innate T cells for enhanced antitumor reactivity","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.4049\/jimmunol.180.9.6044","article-title":"Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer","volume":"180","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fimmu.2017.01401","article-title":"Current advances in \u03b3\u03b4 T cell-based tumor immunotherapy","volume":"8","author":"Lo Presti","year":"2017","journal-title":"Front. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/2326-6066.CIR-18-0647","article-title":"Broad cytotoxic targeting of acute myeloid leukemia by polyclonal delta one T cells","volume":"7","author":"Lorenzo","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.can-03-1501","article-title":"Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice","volume":"64","author":"Lozupone","year":"2004","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1748991","DOI":"10.1080\/2162402X.2020.1748991","article-title":"B7-H3 inhibits the IFN-\u03b3-dependent cytotoxicity of V\u03b39V\u03b42 T cells against colon cancer cells","volume":"9","author":"Lu","year":"2020","journal-title":"OncoImmunology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e003441","DOI":"10.1136\/jitc-2021-003441","article-title":"Off-the-shelf V\u03b41 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma","volume":"9","author":"Makkouk","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood-2009-07-234211","article-title":"Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement","volume":"116","author":"Maniar","year":"2010","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"593562","DOI":"10.1155\/2014\/593562","article-title":"Tumor-activated TCR\u03b3\u03b4\u207a T cells from gastric cancer patients induce the antitumor immune response of TCR\u03b1\u03b2\u207a T cells via their antigen-presenting cell-like effects","volume":"2014","author":"Mao","year":"2014","journal-title":"J. Immunol. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.4049\/jimmunol.1202959","article-title":"Proinflammatory V\u03b42+T cells populate the human intestinal mucosa and enhance IFN-\u03b3 production by colonic \u03b1\u03b2T cells[J]","volume":"191","author":"McCarthy","year":"2013","journal-title":"J. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1084\/jem.20050810","article-title":"Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity","volume":"202","author":"M\u00fcnz","year":"2005","journal-title":"J. Exp. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ejcts.2009.11.051","article-title":"A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells","volume":"37","author":"Nakajima","year":"2010","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ni.2247","article-title":"Intrathymic programming of effector fates in three molecularly distinct \u03b3\u03b4 T cell subtypes","volume":"13","author":"Narayan","year":"2012","journal-title":"Nat. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/14653249.2010.515581","article-title":"Zoledronate-activated V\u03b39\u03b3\u03b4 T cell-based immunotherapy is feasible and restores the impairment of \u03b3\u03b4 T cells in patients with solid tumors","volume":"13","author":"Noguchi","year":"2011","journal-title":"Cytotherapy"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1182\/blood-2011-01-328526","article-title":"DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by \u03b3\u03b4 T lymphocytes","volume":"118","author":"Nussbaumer","year":"2011","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/0008-5472.CAN-13-0675","article-title":"Novel bispecific antibodies increase \u03b3\u03b4 T-cell cytotoxicity against pancreatic cancer cells","volume":"74","author":"Oberg","year":"2014","journal-title":"Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.4049\/jimmunol.1402200","article-title":"Adoptive immunotherapy of epithelial ovarian cancer with V\u03b39V\u03b42 T cells, potentiated by liposomal alendronic acid","volume":"193","author":"Parente-Pereira","year":"2014","journal-title":"J. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.immuni.2007.05.020","article-title":"Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway","volume":"27","author":"Peng","year":"2007","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nature06051","article-title":"Early events in the thymus affect the balance of effector and regulatory T cells","volume":"444","author":"Pennington","year":"2006","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0065-2776(05)87002-6","article-title":"The integration of conventional and unconventional T cells that characterizes cell-mediated responses","volume":"87","author":"Pennington","year":"2005","journal-title":"Adv. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00018-018-2788-x","article-title":"Regulatory functions of \u03b3\u03b4 T cells","volume":"75","author":"Peters","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive V\u03b42-expressing \u03b3\u03b4 T cells","volume":"71","author":"Peters","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/14653249.2011.623693","article-title":"Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate\/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity","volume":"14","author":"Poonia","year":"2012","journal-title":"Cytotherapy"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e4909","DOI":"10.1097\/MD.0000000000004909","article-title":"In vivo expansion and activation of \u03b3\u03b4 T cells as immunotherapy for refractory neuroblastoma: A phase 1 study","volume":"95","author":"Pressey","year":"2016","journal-title":"Medicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cyto.2015.09.011","article-title":"Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis","volume":"89","author":"Qian","year":"2017","journal-title":"Cytokine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"eaay5516","DOI":"10.1126\/science.aay5516","article-title":"Butyrophilin 2A1 is essential for phosphoantigen reactivity by \u03b3\u03b4 T cells","volume":"367","author":"Rigau","year":"2020","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2141.2004.05077.x","article-title":"Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity","volume":"126","author":"Rischer","year":"2004","journal-title":"Br. J. Haematol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14737159.2018.1470929","article-title":"PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy","volume":"18","author":"Romano","year":"2018","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2020.01347","article-title":"Gamma-delta CAR-T cells show CAR-directed and independent activity against leukemia","volume":"11","author":"Rozenbaum","year":"2020","journal-title":"Front. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fimmu.2018.01271","article-title":"Myeloid-derived suppressor cells specifically suppress IFN-\u03b3 production and antitumor cytotoxic activity of v\u03b42 T cells","volume":"9","author":"Sacchi","year":"2018","journal-title":"Front. Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/cji.0b013e318207ecfb","article-title":"Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded \u03b3\u03b4Tcells: a phase I clinical study","volume":"34","author":"Sakamoto","year":"2011","journal-title":"J. Immunother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e005400","DOI":"10.1136\/jitc-2022-005400","article-title":"Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia","volume":"10","author":"S\u00e1nchez Mart\u00ednez","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","article-title":"The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells","volume":"40","author":"Sandstrom","year":"2014","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jcyt.2021.02.002","article-title":"Adoptive \u03b3\u03b4T-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancer","volume":"23","author":"Sato","year":"2021","journal-title":"Cytotherapy"},{"key":"B93","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fimmu.2014.00601","article-title":"Cancer immunotherapy using \u03b3\u03b4T cells: Dealing with diversity","volume":"5","author":"Scheper","year":"2014","journal-title":"Front. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00262-019-02469-8","article-title":"Suppressive activity of V\u03b42+ \u03b3\u03b4 T cells on \u03b1\u03b2 T cells is licensed by TCR signaling and correlates with signal strength","volume":"69","author":"Schilbach","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"B95","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00002371-200009000-00004","article-title":"Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells","volume":"23","author":"Schilbach","year":"2000","journal-title":"J. Immunother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","article-title":"Translating gammadelta (\u03b3\u03b4) T cells and their receptors into cancer cell therapies","volume":"19","author":"Sebestyen","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2012.03.016","article-title":"Migration of \u03b3\u03b4 T cells in steady-state conditions","volume":"147","author":"Shekhar","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"\u0393\u03b4 T cells: Pleiotropic immune effectors with therapeutic potential in cancer","volume":"19","author":"Silva-Santos","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3892\/ijo.2016.3403","article-title":"Hepatocellular carcinoma cell sensitivity to V\u03b39V\u03b42 T lymphocyte-mediated killing is increased by zoledronate","volume":"48","author":"Sugai","year":"2016","journal-title":"Int. J. Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s002620050014","article-title":"Gammadelta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis","volume":"48","author":"Thomas","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.4049\/jimmunol.0804288","article-title":"Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes","volume":"182","author":"Todaro","year":"2009","journal-title":"J. Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/ijc.23365","article-title":"V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs-rituximab and trastuzumab","volume":"122","author":"Tokuyama","year":"2008","journal-title":"Int. J. Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/CJI.0b013e3181b51447","article-title":"Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells","volume":"33","author":"Traxlmayr","year":"2010","journal-title":"J. Immunother."},{"key":"B104","doi-asserted-by":"publisher","first-page":"E9056","DOI":"10.1073\/pnas.1712883114","article-title":"Human papillomavirus oncoproteins induce a reorganization of epithelial-associated \u03b3\u03b4 T cells promoting tumor formation","volume":"114","author":"Van Hede","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4049\/jimmunol.174.3.1338","article-title":"Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma","volume":"174","author":"Viey","year":"2005","journal-title":"J. Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/cam4.196","article-title":"Intraperitoneal injection of in vitro expanded V\u03b39V\u03b42 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer","volume":"3","author":"Wada","year":"2014","journal-title":"Cancer Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/eji.200940157","article-title":"Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis","volume":"40","author":"Wakita","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1182\/blood-2021-149095","article-title":"Induced pluripotent stem cell-derived gamma delta CAR-T cells for cancer immunotherapy","volume":"138","author":"Wallet","year":"2021","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e1353858","DOI":"10.1080\/2162402X.2017.1353858","article-title":"Tumor-infiltrating \u03b3\u03b4T cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer","volume":"6","author":"Wang","year":"2017","journal-title":"OncoImmunology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.4066\/biomedicalresearch.29-18-921","article-title":"A method for detecting intracellular IL-2 in \u03b3\u03b4T cells","volume":"29","author":"Wang","year":"2018","journal-title":"Biomed. Res."},{"key":"B111","first-page":"9644","article-title":"Inhibitory effect of the mitogen activated protein kinase specific inhibitor PD98059 on Mtb-Ag-activated \u03b3\u03b4\u03a4 cells","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cam4.942","article-title":"Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II\/III gastric cancer","volume":"6","author":"Wang","year":"2017","journal-title":"Cancer Med."},{"key":"B113","first-page":"9597","article-title":"Research progress on the mechanism of \u03b3\u03b4T cells inpathogenic microbial infection[J]","volume":"12","author":"Wang","year":"2019","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B114","first-page":"7374","article-title":"Increased values of peripheral blood \u03b3\u03b4T cells, Th17 cells, IL-17, ALT, AST, TB, and DB are closely related to the severity of chronic Hepatitis B[J]","volume":"12","author":"Wang","year":"2019","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B115","first-page":"7183","article-title":"Auxiliary diagnostic value of \u03b3\u03b4\u03a4 cell, IL-17, and IFN-\u03b3 levels in peripheral blood and bronchoalveolar lavage fluid for lung cancer complicated with chronic obstructive pulmonary disease[J]","volume":"11","author":"Wei","year":"2018","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"804347","DOI":"10.1155\/2015\/804347","article-title":"Interleukin-17 could promote breast cancer progression at several stages of the disease","volume":"2015","author":"Welte","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"B117","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fimmu.2014.00598","article-title":"Human gamma delta T regulatory cells in cancer: Fact or fiction[J]?","volume":"5","author":"Wesch","year":"2014","journal-title":"Front. Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gammadelta T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e992749","DOI":"10.4161\/2162402X.2014.992749","article-title":"Ex vivo expanded human circulating V\u03b41 \u03b3\u03b4T cells exhibit favorable therapeutic potential for colon cancer","volume":"4","author":"Wu","year":"2014","journal-title":"OncoImmunology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.3892\/ol.2016.5066","article-title":"The effect of activated M\u03d51 on \u03b3\u03b4T cell-mediated killing of gastric cancer cells in vitro","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol. Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.4049\/jimmunol.0901772","article-title":"Human gamma delta T cells: A lymphoid lineage cell capable of professional phagocytosis","volume":"183","author":"Wu","year":"2009","journal-title":"J. Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3872\/j.issn.1007-385X.2017.03.003","article-title":"Killing activity in vitro of \u03b3\u03b4 T cells against human hematologic neoplasms cells[J]","volume":"24","author":"Xiao","year":"2017","journal-title":"Chin. J. Cancer Biother"},{"key":"B124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3760\/cma.j.issn.0253-3766.2018.04.002","article-title":"Establishment of the culture system of \u03b3\u03b4 T cells in vitro and the anti-tumor effect","volume":"40","author":"Xie","year":"2018","journal-title":"Chin. J. Oncol."},{"key":"B125","first-page":"992","article-title":"Distribution and clonality of T cell receptor V\u03b3 and V\u03b4 subfamily in peripheral blood of patients with allergic rhinitis before and after immunotherapy","volume":"46","author":"Yang","year":"2011","journal-title":"Chin J Otolaryngology Head Neck Surg."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.4049\/jimmunol.1202369","article-title":"Tumor-derived \u03b3\u03b4 regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence","volume":"190","author":"Ye","year":"2013","journal-title":"J. Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1158\/0008-5472.CAN-13-0348","article-title":"Specific recruitment of \u03b3\u03b4 regulatory T cells in human breast cancer","volume":"73","author":"Ye","year":"2013","journal-title":"Cancer Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2012.12.015","article-title":"The functional impairment of HCC-infiltrating \u03b3\u03b4 T cells, partially mediated by regulatory T cells in a TGF\u03b2- and IL-10-dependent manner","volume":"58","author":"Yi","year":"2013","journal-title":"J. Hepatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s41467-022-29012-1","article-title":"Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma","volume":"13","author":"Zakeri","year":"2022","journal-title":"Nat. Commun."},{"key":"B130","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12032-021-01474-1","article-title":"Adoptive cell therapy of patient-derived renal cell carcinoma xenograft model with IL-15-induced \u03b3\u03b4T cells","volume":"38","author":"Zhang","year":"2021","journal-title":"Med. Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ol.2020.12188","article-title":"Association between \u03b1\u03b2 and \u03b3\u03b4 T-cell subsets and clinicopathological characteristics in patients with breast cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"B132","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3760\/cma.j.cn112309-20200618-00322","article-title":"Expression of \u03b3\u03b4T and CD4+ CD25+ T cells in peripheral blood of HIV-infected patients\/AIDS patients and their correlation[J]","volume":"41","author":"Zhao","year":"2021","journal-title":"Chin. J. Microbiol. Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"8746264","DOI":"10.1155\/2021\/8746264","article-title":"CD3+T, CD4+T, CD8+T, and CD4+T\/CD8+T ratio and quantity of \u03b3\u03b4T cells in peripheral blood of HIV-infected\/AIDS patients and its clinical significance","volume":"2021","author":"Zhao","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1365-3083.2001.00827.x","article-title":"Distinct tumour specificity and IL-7 requirements of CD56(-)and CD56(+) subsets of human gamma delta T cells","volume":"53","author":"Zheng","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ijc.1198","article-title":"Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model","volume":"92","author":"Zheng","year":"2001","journal-title":"Int. J. Cancer"},{"key":"B136","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12072-019-09969-w","article-title":"An imbalance between stellate cells and \u03b3\u03b4T cells contributes to hepatocellular carcinoma aggressiveness and recurrence","volume":"13","author":"Zhou","year":"2019","journal-title":"Hepatol. Int."},{"key":"B137","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.18632\/oncotarget.13051","article-title":"\u03b3\u03b4 T cells in cancer immunotherapy","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1077419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:27:06Z","timestamp":1672846026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1077419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":137,"alternative-id":["10.3389\/fgene.2022.1077419"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1077419","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1077419"}}